← Eichor
Study identifier: NCT06586424 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Prognostic Value of Anion Gap in Predicting Major Adverse Cardiovascular Events Among Patients With ST-Segment Elevation Myocardial Infarction

Condition: ST-segment Elevation Myocardial Infarction (STEMI)  ·  Sponsor: Universitas Diponegoro

PhaseN/A
Planned participants80
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

This study aims to evaluate the prognostic value of the anion gap in predicting major adverse cardiovascular events among patients with ST-segment elevation myocardial infarction. Researchers will collect information based on hospital registry as secondary data of in patient who had diagnosed as ST-segment elevation myocardial infarction and underwent primary percutaneous coronary intervention. The data consist of demographic data, clinical presentation, laboratory, and angiography result were collected from hospital registry by reviewing medical record. Then, the data was analyzed by using IBM SPSS Statistics v26.

This description comes directly from the study's public registry record.

Talk to the study team

Leo Deddy Pradipta  ·  +6281316499074  ·  dancingdeagle@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Dr. Kariadi Central General HospitalSemarang, Central of Java, IndonesiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06586424